Insider trade

23.4.2024 17:00:00 CEST | Thor Medical ASA | Mandatory notification of trade
primary insiders

Thor Medical ASA (the "Company") has granted share options to employees and
senior management.

The Company has today issued 4 800 000 share options, equal to 1.99% of total
shares in the Company, to senior management at an exercise price at NOK 1.0822.
The options are granted in accordance with the Company's guidelines for
remuneration of senior executives and board members, as approved by Thor
Medical's annual general meeting held 11 April 2024.

Each option provides a right to acquire one share at the exercise price, equal
to the volume-weighted share price over the last ten trading days prior to
grant. 1.600.000 of the share options will vest 12 months after the grant day,
while the remaining share options will vest over the next 24 months with 133.333
options on the last day of each month following the initial vesting. The share
options need to be exercised no later than five years after the initial award.
The total gross benefit for exercised share options under this grant shall be
limited to the grantee's total base salary of the three-year period.

2.700.000 share options were granted to Sindre Hassfjell, Chief Technological
Officer, and 2.100.000 share options were granted to Astrid Liland, Vice
President EHS, both being primary insider in the Company. Primary insider
notifications pursuant to the market abuse regulation article 19 is attached.

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

* Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.no

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/3055/4367/Download%20announcement
%20as%20PDF.pdf

Thor Medical - Sindre Hassfjell - primary insider notification MAR.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/3055/4363/Thor%20Medical%20-%20Si
ndre%20Hassfjell%20-%20primary%20insider%20notification%20MAR.pdf

Thor Medical - Astrid Liland - primary insider notification MAR.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/3055/4364/Thor%20Medical%20-%20As
trid%20Liland%20-%20primary%20insider%20notification%20MAR.pdf